Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTJ073B)

DTT Name Ribosome (hRBS)
Gene Name hRBS
DTT Type
Clinical trial target
 [1]
UniProt ID
NOUNIPROTAC
TTD ID
T58184

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
2 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
ELX-02 DMK3C4L Cystic fibrosis CA25 Phase 2 [2]
TST-10088 DMT5AEF Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2009 Nov;31(9):597-633.
2 A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects. Clin Pharmacol Drug Dev. 2021 Aug;10(8):859-869.